Quantum-Si Incorporated (QSI)

NASD · Healthcare · Medical Devices · USA

Quantum-Si Incorporated is a micro cap company (market value under $300 million) in the Medical Devices industry.

Quantum-Si Incorporated is a life sciences company developing a proprietary single-molecule detection platform for proteomics research. The company offers the Platinum line of next-generation protein sequencing instruments, analysis software, and consumable kits enabling researchers and clinicians to analyze proteins in parallel rather than sequentially.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Quantum-Si Incorporated stock.

Our verdict on QSI

Not valued: We cannot value this company yet.

We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.

ETFs with the most weight in QSI

5 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than QSI in Medical Devices

61 more in this industry show a wider margin of safety.

Is QSI undervalued or overvalued?

We do not publish a verdict on QSI yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of QSI?

We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.